University of Wisconsin - Madison

Alzheimer's Disease Research Study Seeking Women over the Age of 65

Tue, June 27, 2023 1:40 PM | Anonymous member (Administrator)

Craig Atwood, PhD, is conducting a research study at the University of Wisconsin-Madison Department of Medicine to see if the drug Eligard (leuprolide acetate) may be effective against Alzheimer’s disease in women.

Have you or a loved one been diagnosed with Mild Cognitive Impairment or Alzheimer’s Disease? This study is open to women over the age of 65 diagnosed with Alzheimer’s Disease who are taking a stable dose of a cholinesterase inhibitor medication such as donepezil (Aricept). Participants must also have a study partner (friend or family member) who can accompany them to all study visits.

Study Activities: Our study team will ask you to complete eight study visits spread out over one year.

  • There will be an injection of the study drug (Leuprolide or placebo) four times over the one-year study
  • Study visits will include tests of thinking abilities, blood tests, two MRI scans, and one PET scan
  • Some parts of some visits may be done remotely via phone, computer, or other electronic means

compensation: For participating in our study, participants will be paid $50 for each completed study visit and you may be eligible to be reimbursed for travel costs depending on the distance traveled.

Interested?    You can fill out the interest form here: Study Interest Form

You can also call, text, email, or visit our website for more information:

608-263-2704 | | LUCINDA

Feedback, questions, website problems - contact us at: 

Copyright © UWRA  2018. All rights reserved.

For More Information Contact UWRA

Sandi Haase, Executive Director

UW-Madison Retirement Association

21 North Park Street, Room 7205

Madison, WI 53715-1218


Powered by Wild Apricot Membership Software